Alan J. Gelenberg

13.3k total citations · 3 hit papers
158 papers, 8.7k citations indexed

About

Alan J. Gelenberg is a scholar working on Pharmacology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Alan J. Gelenberg has authored 158 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pharmacology, 64 papers in Psychiatry and Mental health and 21 papers in Clinical Psychology. Recurrent topics in Alan J. Gelenberg's work include Treatment of Major Depression (64 papers), Schizophrenia research and treatment (23 papers) and Bipolar Disorder and Treatment (22 papers). Alan J. Gelenberg is often cited by papers focused on Treatment of Major Depression (64 papers), Schizophrenia research and treatment (23 papers) and Bipolar Disorder and Treatment (22 papers). Alan J. Gelenberg collaborates with scholars based in United States, Japan and United Kingdom. Alan J. Gelenberg's co-authors include Jerrold F. Rosenbaum, Madhukar H. Trivedi, Michael E. Thase, John C. Markowitz, Paul Freeman, Alan F. Schatzberg, Martin B. Keller, Michael E. Thase, Katherine L. Wisner and A. John Rush and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

Alan J. Gelenberg

152 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

2010 995 citations Alan J. Gelenberg, Madhukar H. Trivedi et al. profile →
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

2006 535 citations Maurizio Fava, Madhukar H. Trivedi et al. profile →
Collaborative Care to Improve the Management of Depressive Disorders

2012 338 citations Anilkrishna B. Thota, Theresa Ann Sipe et al. American Journal of Preventive Medicine profile →

Peers

Countries citing papers authored by Alan J. Gelenberg

Since Specialization

Citations

This map shows the geographic impact of Alan J. Gelenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan J. Gelenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan J. Gelenberg more than expected).

Fields of papers citing papers by Alan J. Gelenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan J. Gelenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan J. Gelenberg. The network helps show where Alan J. Gelenberg may publish in the future.

Co-authorship network of co-authors of Alan J. Gelenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Alan J. Gelenberg. A scholar is included among the top collaborators of Alan J. Gelenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan J. Gelenberg. Alan J. Gelenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture 2016 ·The Journal of Clinical Psychiatry ·Erika F.H. Saunders, Christopher E. Ramsden, (unknown), Alan J. Gelenberg, John M. Davis, Stanley I. Rapoport	9
2	Effects of Mental Health Benefits Legislation 2015 ·American Journal of Preventive Medicine ·Theresa Ann Sipe, Ramona Finnie, (unknown), Shuli Qu, (unknown), Anilkrishna B. Thota, Robert A. Hahn, Ron Z. Goetzel, Kevin D. Hennessy, Lela R. McKnight-Eily, Daniel P. Chapman, Clinton W. Anderson, Susan T. Azrin, Ana F. Abraído‐Lanza, Alan J. Gelenberg, (unknown), Donald E. Nease	19
3	Sleep quality during euthymia in bipolar disorder: the role of clinical features, personality traits, and stressful life events 2013 ·International Journal of Bipolar Disorders ·Erika F.H. Saunders, Danielle M. Novick, Julio Fernández‐Mendoza, Masoud Kamali, Kelly A. Ryan, Scott A. Langenecker, Alan J. Gelenberg, Melvin G. McInnis	40
4	Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release 2010 ·Journal of Affective Disorders ·Madhukar H. Trivedi, David L. Dünner, Susan G. Kornstein, Michael E. Thase, John Zajecka, Anthony J. Rothschild, Edward S. Friedman, Richard C. Shelton, Martin B. Keller, James H. Kocsis, Alan J. Gelenberg	34
5	A Review of Current Guidelines for Depression Treatment 2010 ·The Journal of Clinical Psychiatry ·Alan J. Gelenberg	104
6	Depression Symptomatology and Neurobiology 2010 ·The Journal of Clinical Psychiatry ·Alan J. Gelenberg	16
7	Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders 2009 ·Journal of Child and Adolescent Psychopharmacology ·Jaswinder K. Ghuman, Michael G. Aman, Luc Lecavalier, Mark A. Riddle, Alan J. Gelenberg, Ron Wright, Sydney Rice, (unknown), Carolyn Fort	63
8	Prospective, Naturalistic, Pilot Study of Open-Label Atomoxetine Treatment in Preschool Children with Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of Child and Adolescent Psychopharmacology ·Jaswinder K. Ghuman, Michael G. Aman, (unknown), (unknown), Alan J. Gelenberg, Ron Wright, Sydney Rice, Carolyn Fort	22
9	Omega-3 fatty acids and supportive psychotherapy for perinatal depression: A randomized placebo-controlled study 2008 ·Journal of Affective Disorders ·Marlene P. Freeman, Melinda F. Davis, Priti Sinha, Katherine L. Wisner, Joseph R. Hibbeln, Alan J. Gelenberg	152
10	Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study 2007 ·The Journal of Clinical Psychiatry ·James H. Kocsis, Michael E. Thase, Madhukar H. Trivedi, Richard C. Shelton, Susan G. Kornstein, Charles B. Nemeroff, Edward S. Friedman, Alan J. Gelenberg, David L. Dünner, Robert M. A. Hirschfeld, Anthony J. Rothschild, James M. Ferguson, Alan F. Schatzberg, John Zajecka, Ronald Pedersen, Bing Chun Yan, Saeed Ahmed, Jeff Musgnung, Philip T. Ninan, Martín Keller	46
11	Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus 2006 ·Archives of General Psychiatry ·Patrick J. Lustman, Ray E. Clouse, Billy D. Nix, Kenneth E. Freedland, Eugene H. Rubin, Janet B. McGill, Monique Williams, Alan J. Gelenberg, Paul Ciechanowski, Irl B. Hirsch	152
12	Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction 2006 ·International Journal of Impotence Research ·H. George Nurnberg, Maurizio Fava, Alan J. Gelenberg, Paula L. Hensley, Susan Paine	9
13	Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder 2005 ·Archives of General Psychiatry ·Michael R. Liebowitz, Alan J. Gelenberg, Dennis J. Munjack	104
14	Metabolic Effects of Treatment With Atypical Antipsychotics 2004 ·The Journal of Clinical Psychiatry ·John M. Kane, (unknown), Daniel E. Casey, Christoph U. Correll, Alan J. Gelenberg, Samuel Klein, John W. Newcomer	58
15	Effectiveness of St John's wort in major depression: a randomized controlled trial. 2001 ·PubMed ·Richard C. Shelton, Martín Keller, Alan J. Gelenberg, David L. Dünner, Robert M. A. Hirschfeld, Michael E. Thase, James Russell, R. Bruce Lydiard, (unknown), (unknown), (unknown), David J. Hellerstein, Paul J. Goodnick, Gabor I. Keitner, Stephen M. Stahl, Uriel Halbreich	241
16	Efficacy of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Men Taking Serotonin Reuptake Inhibitors 2001 ·American Journal of Psychiatry ·H. George Nurnberg, Alan J. Gelenberg, T. B. Hargreave, Wilma Harrison, Richard L. Siegel, Mark D. Smith	60
17	Risk-Benefit Decision Making for Treatment of Depression During Pregnancy 2000 ·American Journal of Psychiatry ·Katherine L. Wisner, Deborah A. Zarin, Eric S. Holmboe, Paul S. Appelbaum, Alan J. Gelenberg, Henrietta L. Leonard, Ellen Frank	185
18	Sexual side effects of antidepressant drugs 2000 ·Current Psychiatry Reports ·Alan J. Gelenberg, (unknown), H. George Nurnberg	9
19	The treatment of chronic depression, part 2: A double-blind, randomized trial of sertraline and imipramine 1999 ·Martín Keller, Alan J. Gelenberg, Robert M. A. Hirschfeld	5
20	Biological therapies in psychiatry newsletter 1989 ·Alan J. Gelenberg	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact